CML patients in the molecular era – report of five years experience of diagnosis and treatment in a single center

por Voican, I, Vladareanu, AM, Bumbea, H, Barsan, L, Vasile, D
Publicado 2013

Chronic myeloid leukemia therapy in the era of tyrosine kinase inhibitors. The first molecular targeted treatment

por Bumbea, H, Vladareanu, AM, Cisleanu, D, Barsan, L, Onisai, M, Voican, I
Publicado 2010

Correlations of hematological parameters with bone marrow findings in chronic lymphoproliferative disorders associated with hepatitis viruses

por Ciufu, C, Arama, V, Bumbea, H, Dobrea, C, Ion, I, Vladareanu, AM
Publicado 2013

The evaluation of the outcome in myelodysplastic patients by using non-cytogenetic prognostic scores

por Căzăceanu, O, Vlădăreanu, AM, Bumbea, H, Begu, M, Onisai, M, Enache, C
Publicado 2014

CD 200 – A useful marker in chronic B lymphoprolipherative disorders

por Iova, A, Vlădăreanu, A, Bumbea, H, Begu, M, Vasile, D, Andruş, E
Publicado 2012

Splanchnic vein thrombosis, the onset manifestation in JAK positive Chronic Myeloproliferative Disorders Neoplasms

por Vladareanu, AM, Popov, V, Bumbea, H, Onisai, M, Ilea, A, Dobrea, C, Miulescu, M
Publicado 2011

The impact of hepatitis viruses on chronic lymphoproliferative disorders; preliminary results

por Vladareanu, AM, Ciufu, C, Neagu, AM, Onisai, M, Bumbea, H, Ciufu, C, Vintilescu, AM, Dobrea, C, Arama, V, Mihailescu, R, Arama, S
Publicado 2010

P829: A PHASE III RANDOMIZED CLINICAL TRIAL COMPARING SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) WITH REFERENCE ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

por Jang, J. H., Demichelis Gomez, R., Bumbea, H., Nogaieva, L., Wong, L. L. L., Lim, S. M., Park, J., Kim, Y., Cho, S.
Publicado 2022

PB2259: MONOCYTE’S INVOLVEMENT IN INFLAMMATORY RESPONSE IN COVID-19 INFECTION IN CHRONIC RENAL DISEASE

por Bumbea, V., Bumbea, H., Ardelean, L., Radulescu, L., Damian, L., Dumitru, I., Lambert, C., Popov, V., Tomuleasa, C., Vladareanu, A.-M.
Publicado 2022

The lymphocyte immunophenotypical pattern in chronic lymphocytic leukemia associated with hepatitis viral infections

por Bumbea, H, Vladareanu, AM, Vintilescu, A, Radesi, S, Ciufu, C, Onisai, M, Baluta, C, Begu, M, Dobrea, C, Arama, V, Streinu–Cercel, A, Arama, S
Publicado 2011

P1602: THE ASSESSMENT OF LYMPHOPENIA AS RISK FACTOR FOR UNFAVORABLE EVOLUTION OF PATIENTS WITH SEVERE FORM OF COVID 19

por Popov, V., Iliescu, L., Grigorie, A., Pirvu, C., Constantin, O., Badea, A., Badoiu Niculae, M. D., Rus, A., Calen, A., Bumbea, H., Mastalier, B., Andreescu, M.
Publicado 2022